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Abstract
Long-range communication is essential for the function of members of the Cys-loop family of
neurotransmitter-gated ion channels. The involvement of the peptide backbone in binding-induced
conformational changes that lead to channel gating in these membrane proteins is an interesting,
but unresolved issue. To probe the role of the peptide backbone, we have incorporated a series of
α-hydroxy acid analogues into the β-sheet rich extracellular domain of the muscle subtype of the
nicotinic acetylcholine receptor, the prototypical Cys-loop receptor. Specifically, mutations were
made in β-strands 7 and 10 of the α-subunit. A number of single backbone mutations in this region
were well-tolerated. However, simultaneous introduction of two proximal backbone mutations led
to surface-expressed, non-functional receptors. Together, these data suggest that while the receptor
is remarkably robust in its ability to tolerate single amide-to-ester mutations throughout these β-
strands, more substantial perturbations to this region have a profound effect on the protein. These
results support a model in which backbone movements in the outer β-sheet are important for
receptor function.
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Introduction
An essential feature of allsoteric proteins is that they are innately dynamic molecules, with
the Cys-loop superfamily of ligand-gated ion channels providing a classic example. These
neurotransmitter receptors are involved in mediating fast synaptic transmission throughout
the central and peripheral nervous systems.[1–5] They are among the molecules of learning,
memory, and sensory perception, and they are implicated in numerous neurological
disorders, including Alzheimer’s disease, Parkinson’s disease, and schizophrenia. The
muscle subtype of the nicotinic acetylcholine receptor (nAChR) is the prototypical Cys-loop
receptor. It is a pentamer of homologous subunits arranged pseudo-symmetrically around a
central ion-conducting pore. The extracellular domain is largely comprised of β-sheet
structure and contains the agonist binding site. The agonist binding site itself is shaped by
discontinuous flexible loop regions that meet at the interface between subunits. The primary
contributors to the agonist binding site are in the α subunit, with additional contributions
from the complementary subunits (γ and δ). The transmembrane domain of each subunit is
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made up of four membrane-spanning α-helices, with one from each subunit lining the pore.
Binding of a small molecule agonist in the extracellular domain triggers a series of
conformational changes that leads to the opening of the channel gate some 60Å away.
Long-range communication is clearly critical in the function of these receptors.[6,7] Various
models for how this communication occurs have been proposed, from specific side chain
interactions to more rigid large-scale domain movements.[8–11] Recent linear free energy
analysis of the nAChR has given rise to the notion of a “conformational wave”[8] that
emanates from the agonist binding site to the gate of the channel in the transmembrane
domain. It seems likely that some movement must occur in the immediate region of the
binding interaction, with simple side chain movements comprising only a part of the ensuing
conformational wave. Significant movements along the peptide backbone may also play a
critical role in initiating channel gating.
To investigate the involvement of the peptide backbone in binding-induced conformational
changes that lead to channel gating, we have incorporated a series of α-hydroxy acid
analogues into the β-sheet rich extracellular domain of the nAChR (Figure 1). Upon
incorporation of an α-hydroxy acid into a protein, the backbone amide functional group is
replaced by an ester, with two major consequences (Figure 2). First, the ester bond disrupts
the backbone hydrogen bonding pattern associated with β-sheet structure. The ester lacks the
NH hydrogen bond donor, and the ester carbonyl is a weaker hydrogen bond acceptor than
the amide carbonyl. Previous studies on a small 3-stranded β-sheet protein found that the
effect of weakening a hydrogen bond acceptor (the carbonyl) is less destabilizing than
removing the hydrogen bond donor (the NH) by about 0.8 kcal/mol.[12] Second, while the
s-trans planar conformational preference, bond lengths, and bond angles are generally
similar to those of amide bonds, the ester bond possesses much greater backbone flexibility
due to substantial reduction of the rotation barrier around the C-O vs. the C-N single bond.
In the present work, amide-to-ester mutations were made in two critical β-strands that
connect the agonist binding site to the transmembrane region of the receptor (Figure 1). To
our knowledge, this is the first systematic study of amide-to-ester mutations in a β-sheet of a
large allosteric receptor. Specifically, mutations were made in β-strands 7 and 10 (β7 and
β10, respectively) of the β-subunit, disrupting the extensive backbone hydrogen bonding
network in what has been termed the outer β-sheet of the extracellular domain. The rationale
behind studying these strands was two-fold. First, β7 connects the critical cation-π binding
residue in loop B (αW149)[13] to the eponymous Cys-loop, which directly contacts the
transmembrane region. β10 extends from loop C, which contains two other aromatic binding
box residues[14,15], and connects directly to the first transmembrane helix. Second, recent
studies strongly implicate the outer β-sheet in connecting agonist binding to channel gating.
[10,16–19] A study of β7 and β10 in the neuronal α7 nAChR suggests that the rigidity of
this region is crucial in transducing channel gating.[17] Furthermore, previous studies show
that a triad of residues in this region is important in initiating channel gating.[10] These
residues are the C-loop residue αY190, along with αK145 and αD200, on β7 and β10,
respectively. Thus, it seemed reasonable to assume that the outer β-sheet was important for
connecting agonist binding to channel gating, and that backbone dynamics and hydrogen
bonding might be involved. Given that the balance between rigidity and flexibility is
believed to be central to the structure and function of allosteric proteins,[7] involvement of
the peptide backbone in mediating allosteric communication in the nAChR would not be
surprising. Previous studies of backbone esters in ion channels have focused on the role of
backbone flexibility in α-helical domains,[20–22] seeking local movements that directly
influence channel gating. Here we hope to better understand how hydrogen bonding in a
critical β-sheet region that is distal to the channel gate influences receptor function.
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Surprisingly, a number of single backbone mutations in this region were well-tolerated,
producing only modest shifts in EC50 and wild type-like macroscopic current sizes (Imax) in
the majority of cases. However, simultaneous introduction of two backbone mutations either
in the same β-strand separated by a single amino acid or at amino acids sharing a hydrogen
bond between the two β-strands led to surface-expressed, non-functional receptors.
Together, these data suggest that while the receptor is remarkably robust in its ability to
tolerate single amide-to-ester mutations throughout these β-strands, more substantial
perturbations to this region have a profound effect on the protein. Therefore, it would seem
that backbone movements in the outer β-sheet are important for receptor function. This adds
to a growing body of evidence that points to the importance of this region in mediating the
conformational changes that emanate from the agonist binding site to the gate of the
channel.
Results
Single amide-to-ester mutations in β7 and β10 have minimal impact on receptor function
Nine α-hydroxy acids were incorporated into β7 and β10 of the α-subunit extracellular
domain, perturbing a total of 13 hydrogen bonds (Figure 1). In some cases, the α-hydroxy
analogue of the native amino acid was not available. In these instances, conventional
mutagenesis was employed to find an alternative amino acid side chain that had both
minimal effect on receptor function and an available α-hydroxy analogue. The effect of the
amide-to-ester mutation was then compared to the analogous side chain mutant, instead of
the wild-type receptor. Most amide-to-ester mutations produced modest changes in EC50 (<
2-fold) (Figure 3, Table 1). In three cases (αM144, αL199, and αV206) larger, although still
not immense, shifts in the 3.5-4-fold range were seen. ACh-induced whole-cell currents of
receptors with single α-hydroxy mutations were similar to the currents produced by
incorporation of the native amino acid by nonsense suppression.
As EC50 is a composite of both binding and gating phenomena, small shifts in EC50 may
mask a large effect on receptor behavior. Recently, we developed a method to evaluate
whether a loss of function (increase in EC50) mutation in the extracellular domain strongly
impacts receptor gating (rather than agonist binding).[23] The method, termed ELFCAR
(Elucidating Long-range Functional Coupling in Allosteric Receptors), is based on mutant
cycle analysis and produces a value for Ω, the coupling between extracellular domain
residue and a known gating mutation (in this case βL9’S). This method utilizes whole-cell
data to determine whether a mutant that produces a moderate to large increase in EC50 has a
substantial impact on receptor gating, as indicated by Ω >2 ELFCAR is especially valuable
in interpreting moderate increases in EC50, where a dramatic effect on gating might
otherwise be missed. An Ω value near one, however, does not preclude a modest effect on
gating. The three α-hydroxy mutants in this study that produce increases in EC50 – at
positions 144, 201, and 206 – all produce an Ω value near one (0.97, 0.65, and 0.69,
respectively), suggesting no dramatic impact on receptor gating. This method is not
applicable to gain-of-function mutations, so the remaining six mutants could not be
evaluated using ELFCAR. Combined, the data suggest that single α-hydroxy mutations in
this region do not substantially impair receptor gating.
Simultaneous incorporation of two α-hydroxy acid mutations in β7 and β10 produces non-
functional, surface expressed receptors
The impact of disrupting the polypeptide backbone at more than one location was
investigated by simultaneously incorporating two α-hydroxy acids. This was done in two
different ways: amide-to-ester mutations were made either in the same β-strand separated by
a single amino acid (αM144 and αL146 in β-strand 7), or at amino acids sharing a hydrogen
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bond between the two β-strands (αL146 and αI201; Figure 1). Simultaneous incorporation of
the same α-hydroxy (Lah) or amino (Leu, in the case of wild type recovery) acid was done
in both scenarios. This allowed for double suppression using the standard nonsense
suppression methodology (see Materials and Methods). As a large shift in EC50 might have
been anticipated, the double mutation experiments were carried out in the presence of the
βL9’S gating mutation. For mutations that primarily affect binding or have a only moderate
effect on channel gating this mutation lowers the EC50 by about 40-fold, allowing for
reliable EC50 measurement of potentially highly deleterious mutations without
complications from open channel block at high agonist concentrations.
For both double-mutation (Lah) experiments, no whole-cell current was observed in
response to high (>1000 µM) doses of ACh. Wild type recovery (Leu) by nonsense
suppression gave normal whole cell currents in the range of 5 to15 µA. Lack of an
electrophysiological response can indicate that protein folding, subunit assembly, receptor
transport, or receptor function have been impacted.
To determine whether nonfunctional mutant receptors were expressed at the plasma
membrane, the localization of these mutant receptors was studied using single molecule
Total Internal Reflectance Fluorescence (TIRF) microscopy. Mutant and wild type (recovery
by nonsense suppression) receptors were first labelled with biotin conjugated to α-
bungarotoxin and subsequently labelled with streptavidin conjugated to the fluorophore
Alexa488. Fluorescent puncta corresponding to single receptors were clearly visible on the
cell surface (Figure 4B). For the double α-hydroxy-containing receptors, the number of
puncta was between 50 and 70% of the value seen for wild type receptor (recovery by
nonsense suppression) (Figure 4B, Table 2). Based on previous, extensive studies with this
approach,[24] it is clear that double mutant receptors are being surface expressed at a level
such that significant whole-cell current would be observed, if the receptors were functional.
That is, the calculated expected whole-cell currents from the α-hydroxy double mutant
receptors based on puncta density are on the order of 3 to 5 µA (Table 2). Since we can
easily detect this magnitude of Ach-induced current, our results clearly show that non-
functional receptors have been expressed on the oocyte surface. The calculated expected
whole cell currents from the wild type receptors based on puncta density are on the order of
6 to 7 µA, in agreement with the electrophysiological data.
Note that α-bungarotoxin is a potent inhibitor of the nAChR that binds tightly in the same
region[25] as ACh and requires properly folded receptor for tight binding. Thus, successful
α-bungarotoxin binding indicates that the overall structure of the extracellular domain and
binding site were not grossly perturbed. These results indicate that simultaneous
incorporation of two α-hydroxy mutations in this region leads to nonfunctional, surface-
expressed receptors.
Discussion
The β-sandwich structure comprised of “inner” and “outer” β-sheets – first revealed in the
AChBP structure[14,15] and later confirmed in images of the full nAChR[18,26] – is
accepted to be a critical structural feature of Cys-loop receptors. In the present work, we
have probed the robustness of this structure by selectively removing/weakening backbone
hydrogen bonds that define the structure, using backbone ester substitution. The remarkable
generality of nonsense suppression techniques for incorporating unnatural residues into
receptors and channels expressed in Xenopus oocytes makes this study possible. One could
have imagined several outcomes for such experiments. If movement within the sheets is
critical to receptor function, backbone mutations could facilitate receptor gating, perhaps
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even creating constitutively active receptors. Alternatively, if an intact β-sandwich is
essential for receptor function, backbone mutations could disable the receptor.
Here we have focused on the outer β-sheet of the extracellular domain, and in particular on
β7 and β10, which have been proposed to play key roles in receptor function. Perhaps
surprisingly, individual amide-to-ester mutations throughout both strands resulted in
functional receptors with only modest changes in EC50. Evidently, the outer β-sheet is
relatively robust, and the receptor can absorb the loss of a single hydrogen bond in this
region. Interestingly, however, simultaneous replacement of two nearby residues with their
α-hydroxy analogues produced surface-expressed, but non-functional receptors. Using
receptor labelling with fluorescent α-bungarotoxin, and single-molecule imaging by TIRF
microscopy, we demonstrate that the number of double-mutant receptors expressed on the
oocyte is more than adequate to produce measurable currents, if the receptors were
functional. Tight binding by α-bungarotoxin requires proper folding in the region of the
agonist binding site, which is quite near the mutations considered here. In fact, in the α-
bungarotoxin-bound crystal structure of the α1-subunit,[27] residues at the top of both β7
and β10 are in close proximity to the bound α-bungarotoxin molecule. Successful binding of
α-bungarotoxin to the double mutant receptors, as detected by TIRF microscopy, strongly
suggests that the structure of this region is not greatly perturbed.
The implication is that the crucial outer β-sheet of the nAChR is not overly fragile – it can
tolerate the disruption caused by a single backbone substitution – but it must be intact for
receptor function, and apparently two proximal backbone mutations are too disruptive.
Folding, assembly, and transport to the cell surface, however, can still occur in the double
mutants discussed here.
These results can be understood in the context of emerging models of the conformational
changes in the extracellular domain that lead to receptor activation. Recent MD
simulations[19,28] have pointed to a pivotal role for β10 in communicating the inward
motion of the agonist binding site-shaping C-loop to the motions of the transmembrane
domain that eventually produce channel opening. The proposed upward and outward motion
allows αR209 on β10 to approach αE45 on the β2–β3 linker, resulting in an interaction
between these two residues; an interaction that was previously concluded to be important for
coupling agonist binding and channel gating based on mutant cycle analysis of single
channel data.
β7 likewise harbors a residue, αK145, that has been implicated in connecting agonist
binding with channel gating. When agonist binds and the C-loop closes in, a salt bridge
between αK145 on β7 and αD200 on β10 breaks, and αK145 forms a hydrogen bond with
αY190 on the C-loop.[10] This electrostatic rearrangement was proposed to initiate
conformational changes that contribute to opening of the central ion-conducting pore.
Studies of engineered disulfide linkages between β7 and β10 in the α7 nAChR also suggest
that the outer β-sheet plays a role in transmitting agonist binding-induced conformational
changes to the channel gate.[17] Specifically, in the background of a non-desensitizing
mutation, one engineered disulfide-containing receptor could be activated by divalent
cations alone, which normally play a role as allosteric modulators. This implies that reduced
mobility in the outer β-sheet of these receptors results in a lower barrier to channel
activation. These and other researchers[16] have suggested that this β-sheet may act as a
lever, where binding at one end tilts the lever resulting in a movement at the other,
transmembrane-adjacent, end. A certain amount of rigidity in this region seems to be
fundamental to normal receptor function.
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Using this lever analogy, our results suggest that two or more nearby α-hydroxy acid
mutations lead to a more flexible and thus ineffective lever that is unable to communicate
agonist binding events to the transmembrane region of the receptor. Thus, disruption of
hydrogen bonding in the outer β-sheet would seem to interrupt the conformational wave that
connects the agonist binding-induced motions of the C-loop to the subsequent motions of the
transmembrane region.
It is also possible that the loss of hydrogen bonding between these strands could lead to
misalignment of the binding box residues, impairing agonist binding to the receptor.
However, it seems less likely that the binding region of the receptor is grossly malformed,
since α-bungarotoxin is still able to bind to the mutant receptors.
Conclusion
In conclusion, we find that the network of hydrogen bonds formed in the outer β-sheet of the
nAChR is fairly robust, tolerating single amide-to-ester mutations throughout. However,
eliminating two proximal hydrogen bonds completely destroys receptor function, adding
further support to gating models that ascribe important roles to these β-strands of the nAChR
extracellular domain.
Experimental Section
Unnatural Hydroxy Acid Suppression
Synthetic α-hydroxy acids were conjugated to the dinucleotide dCA and ligated to truncated
74-nucleotide tRNA as previously described.[29] Typically, 25 ng of tRNA was injected per
oocyte along with mRNA in a total volume of 50 nL/cell. mRNA was prepared by in vitro
runoff transcription using the Ambion (Austin, TX) T7 mMessage mMachine kit. The site of
interest was mutated to the amber stop codon by standard means, verified by sequencing
through both strands. Mouse muscle embryonic nAChR in the pAMV vector was used. A
total of 4.0 ng of mRNA was injected in an α:β:γ:δ subunit ratio of 10:1:1:1. The ratio of
tRNA to mRNA was typically 1:1. In addition, the α-subunits contain an HA epitope in the
M3–M4 cytoplasmic loop for Western blot studies. Control experiments show that this
epitope does not detectably alter EC50. As a negative control for suppression, truncated 74-
nucleotide tRNA or truncated tRNA ligated to dCA to give a 76mer was co-injected with
mRNA in the same manner as fully charged tRNA. Data from experiments where currents
from these negative controls was greater than 10% of the experimental were excluded. The
positive control for suppression involved wild-type recovery by co-injection with 74-
nucleotide tRNA ligated to wild type amino acid. For suppression at multiple sites, the
tRNA:mRNA ratio was increased to 2:1.
Electrophysiology
Stage V–VI oocytes of Xenopus laevis were employed. Oocyte recordings were made 12–48
h post injection in two-electrode voltage clamp mode using the OpusXpress 6000A
instrument (Axon Instruments, Union City, CA). Oocytes were superfused with a Ca2+-free
ND96 solution at flow rates of 1 mL/min before application, (15 second) 4 mL/min during
drug application, and 3 mL/min during wash. Holding potentials were −60 mV. Data were
sampled at 125 Hz and filtered at 50 Hz. Acetylcholine chloride was purchased from Sigma/
Aldrich/RBI. Solutions ranging from 0.01 mM to 5000 mM were prepared in Ca2+-free
ND96 from a 1 M stock solution. Dose-response data were obtained for a minimum of 8
concentrations of agonists and for a minimum of five cells. Dose-response relations were
fitted to the Hill equation to determine EC50 and Hill coefficient values. The dose-response
relations of individual oocytes were examined and used to determine outliers. The reported
EC50 values are from the curve fit of the averaged data.
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Total Internal Reflection Fluorescence Microscopy
Xenopus oocytes were prepared for single molecule TIRF microscopy as follows. 24–48
hours after injection of mRNA and tRNA, oocytes were incubated in a 0.5 ng/µL solution of
biotin conjugated to α-bungarotoxin (Molecular Probes, Invitrogen, Eugene, OR) for 4– 12
hours. This was followed by two wash steps with a 5 mg/mL bovine serum albumin solution
and one wash with Ca2+-free ND96. Subsequently, oocytes were incubated in a 0.2 ng/µL
solution streptavidin conjugated to the fluorophore Alexa488 (Molecular Probes, Invitrogen,
Eugene, OR) for 15– 30 minutes, followed by two additional wash steps each with BSA and
Ca2+-free ND96. The vitelline membrane of labeled oocytes was removed with forceps
following a 5–10 minute incubation in a hypertonic solution (220 mM sodium aspartate, 10
mM HEPES, 10 mM EDTA, 2 mM MgCl2, pH 7.38). Devitellinized oocytes were
transferred to an imaging chamber with a clean glass coverslip mounted on the microscope
stage with the animal pole oriented toward the coverslip. The TIRF microscope used to
collect the data consists of a Melles-Griot Argon (Ar) ion laser coupled to a fiber optic
which extends to an Olympus TIRF illuminator adapted to a standard inverted IX-71
Olympus microscope (Center Valley, PA). A wavelength of 488 nm was used to excite and
detect the Alexa488 fluorophores, by using the Z488 filter cube from Chroma Technology
Corporation (Rockingham, VT). A 100× 1.45 NA Olympus TIRF objective was used.
Images were captured with a Photometrics Cascade front illuminated CCD camera from
Princeton Instruments (Trenton, NJ). Andor iQ from Andor Technology (South Windsor,
CT) was used to acquire the data. The data were subsequently processed and analyzed with
ImageJ (National Institutes of Health). Puncta were manually counted and densities from ≥6
images and ≥2 oocytes were compiled and averaged. Expected current sizes were calculated
as (#puncta/image frame area)*average oocyte area*single channel conductance.
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Figure 1.
Two views of the nAChR. (A) Overall layout of the receptor. One of the five subunits is
shown in blue, with β7, β9, and β10 highlighted in red, yellow, and green, respectively. (B)
The hydrogen bonding network of the outer β-sheet of the nAChR. Turquoise balls indicate
positions at which the backbone NH was mutated to an oxygen. The black dashed lines
indicate hydrogen bonds that are completely removed or attenuated due as a result of
mutation. Image is based cryo-EM of the full Torpedo receptor (2bg9).[18]
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Figure 2.
Schematic of the backbone amide versus the backbone ester bond in the context of a β-sheet.
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Figure 3.
Characteristics of nAChR with backbone mutations in β-strands 7 and 10. (A) EC50 shifts
for backbone mutations made at nine positions in β7and β10. Modest effects on receptor
function are seen in all cases. (B) Current traces for backbone mutations made at nine
positions in β7and β10.
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Figure 4.
Analysis of non-functional nAChRs containing two amide-to-ester mutations by TIRF
microscopy. (A) Puncta density for receptors labeled with Leu refers to recovery of the wild-
type peptide backbone by nonsense suppression; Lah refers to incorporation of leucine α-
hydroxy; and 76mer indicates the negative control experiment (coinjection of mRNA with a
tRNA molecule that has not been charged with an amino or hydroxy acid). The puncta
density for both Leu and Lah are significantly higher than for either the 76mer or uninjected
oocyte controls (t-test values for Lah vs. 76mer are: P=0.0009 (L146I120); P<0.0001
(L146M144); for Lah vs. uninjected: P= 0.0003 (L146I120); P< 0.0001 (L146M144). Data
are compiled from ≥6 non-overlapping images from ≥2 oocytes. (B) Representative TIRF
images corresponding to the data in (A). Scale bars represent 6 µm.
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Table 1
EC50 and Hill coefficient (±SEM) values for mutations made in this study.
EC50 (µM) nH
WT 46 ± 2 1.8 ± 0.13
αM144Leu 15 ± 0.3 1.7 ± 0.06
αM144Lah 50 ± 0.8 1.7 ± 0.03
αL146Lah 26 ± 0.8 1.3 ± 0.05
αT148Tah 33 ± 3 1.0 ± 0.06
αL199Lah 11 ± 0.5 1.6 ± 0.10
αI201Iah 82 ± 6 1.5 ± 0.12
αT202Tah 24 ± 1 1.4 ± 0.09
αY203Yah 39 ± 0.8 1.9 ± 0.07
αF205Tyr 90 ± 2 1.5 ± 0.05
αF205Yah 67 ±62 1.4 ± 0.13
αV206Vah 170 ± 10 1.9 ± 0.20
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Table 2
Puncta densities and corresponding estimated current sizes from TIRF microscopy experiments. 76mer refers
to unaminoacylated tRNA.
αI201L146 # Puncta/ image frame Calculated current size (µA)
Leu 265 ± 36 7.5 ± 1.0
Lah 179 ± 33 5.1 ± 0.9
76mer 51 ± 10 1.4 ± 0.3
Uninjected 27 ± 5 0.8 ± 0.2
αL146M144
Leu 214 ± 15 6.1 ± 0.4
Lah 121 ± 4 3.4 ± 0.1
76mer 56 ± 5 1.6 ± 0.1
Uninjected 37 ± 4 1.0 ± 0.1
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